Investor relations
Menu
press releases
03/18/2021
PainReform Provides Year-End Business Update and Reports Progress Towards Commencing Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief
03/11/2021
PainReform to Participate at M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference
03/08/2021
PainReform Announces $6.0 Million Private Placement
01/07/2021
PainReform to Present at the H.C. Wainwright Bioconnect 2021 Conference
01/06/2021
PainReform Announces Appointment of Lotus Clinical Research as CRO for Phase 3 Clinical Trial of PRF-110
01/04/2021
